摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(Z)-2-Ethoxy-3-(1H-indol-5-yl)-acrylic acid ethyl ester | 897940-15-7

中文名称
——
中文别名
——
英文名称
(Z)-2-Ethoxy-3-(1H-indol-5-yl)-acrylic acid ethyl ester
英文别名
Ethyl 2-ethoxy-3-(1H-indol-5-yl)-2-propenoate;ethyl 2-ethoxy-3-(1H-indol-5-yl)prop-2-enoate
(Z)-2-Ethoxy-3-(1H-indol-5-yl)-acrylic acid ethyl ester化学式
CAS
897940-15-7
化学式
C15H17NO3
mdl
——
分子量
259.305
InChiKey
AMTDKHHMBSNIRE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    19
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    51.3
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    (Z)-2-Ethoxy-3-(1H-indol-5-yl)-acrylic acid ethyl ester 在 palladium on activated charcoal 氢气 作用下, 以 乙醇 为溶剂, 22.0 ℃ 、101.32 kPa 条件下, 反应 2.0h, 以82%的产率得到rac-2-乙氧基-3-(1H-吲哚-5-基)-丙酸乙酯
    参考文献:
    名称:
    Structure-based design of indole propionic acids as novel PPARα/γ co-agonists
    摘要:
    In the quest for novel PPARalpha/gamma co-agonists as putative drugs for the treatment of type 2 diabetes and dyslipidemia, we have used a structure-based design approach to identify propionic acids with a 1,5-disubstituted indole scaffold as potent PPARalpha/gamma activators. Compounds 13, 24, and 28 are examples of submicromolar dual agonists with different alpha/gamma EC50 ratios that are selective against the delta-isoform. Analysis of the X-ray complex structure of PPARgamma with the indole propionic acid 13 provides a rationalization for some of the observed SAR.
    DOI:
    10.1016/j.bmcl.2006.05.007
  • 作为产物:
    描述:
    5-吲哚甲醛(1,2-二乙氧基-2-氧代乙基)(三苯基)鏻氯化物1,1,2,3-四甲基胍 作用下, 以 二氯甲烷 为溶剂, 反应 40.0h, 以95%的产率得到(Z)-2-Ethoxy-3-(1H-indol-5-yl)-acrylic acid ethyl ester
    参考文献:
    名称:
    Structure-based design of indole propionic acids as novel PPARα/γ co-agonists
    摘要:
    In the quest for novel PPARalpha/gamma co-agonists as putative drugs for the treatment of type 2 diabetes and dyslipidemia, we have used a structure-based design approach to identify propionic acids with a 1,5-disubstituted indole scaffold as potent PPARalpha/gamma activators. Compounds 13, 24, and 28 are examples of submicromolar dual agonists with different alpha/gamma EC50 ratios that are selective against the delta-isoform. Analysis of the X-ray complex structure of PPARgamma with the indole propionic acid 13 provides a rationalization for some of the observed SAR.
    DOI:
    10.1016/j.bmcl.2006.05.007
点击查看最新优质反应信息

文献信息

  • Indolyl derivatives
    申请人:——
    公开号:US20040053979A1
    公开(公告)日:2004-03-18
    Compounds of formula I are provided 1 as well as pharmaceutically acceptable salts and esters thereof, wherein R 1 to R 8 , A, A 1 and n have the significance indicated in the specification.
    提供了式I的化合物,以及其药用可接受的盐和酯,其中R1至R8,A,A1和n具有规范中指示的含义。
  • N-SUBSTITUTED-1H-INDOL-5-PROPIONIC ACID COMPOUNDS AS PPAR AGONISTS USEFUL FOR THE TREATMENT OF DIABETES
    申请人:F. Hoffmann-La Roche AG
    公开号:EP1539746A1
    公开(公告)日:2005-06-15
  • US6890947B2
    申请人:——
    公开号:US6890947B2
    公开(公告)日:2005-05-10
  • [EN] N-SUBSTITUTED-1H-INDOL-5-PROPIONIC ACID COMPOUNDS AS PPAR AGONISTS USEFUL FOR THE TREATMENT OF DIABETES<br/>[FR] COMPOSES D'ACIDE 1H-INDOL-5-PROPIONIQUE A SUBSTITUTION N EN TANT QU'AGONISTES DE PPAR UTILES DANS LE TRAITEMENT DU DIABETE
    申请人:HOFFMANN LA ROCHE
    公开号:WO2004024726A1
    公开(公告)日:2004-03-25
    Compounds of formula (I), as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R8, A, A1 and n have the significance given in claim 1 can be used in the form of pharmaceutical preparations.
查看更多